NPI: 1538244918 · LEXINGTON, KY 40503 · General Acute Care Hospital · NPI assigned 10/26/2006
Authorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | CARRICO, RICHARD (CFO) |
| NPI Enumeration Date | 10/26/2006 |
Other providers sharing the same authorized official: CARRICO, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 232,439 | $9.76M |
| 2019 | 241,876 | $10.68M |
| 2020 | 267,505 | $13.16M |
| 2021 | 340,179 | $15.59M |
| 2022 | 348,198 | $13.72M |
| 2023 | 395,646 | $16.47M |
| 2024 | 353,688 | $18.69M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 28,447 | 23,795 | $7.06M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 42,903 | 36,939 | $7.02M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10,628 | 9,434 | $4.38M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 8,702 | 7,825 | $3.53M |
| 93458 | 3,288 | 1,384 | $3.35M | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,976 | 7,109 | $3.28M |
| G0378 | Hospital observation service, per hour | 9,555 | 7,406 | $3.00M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7,512 | 6,703 | $2.67M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 6,207 | 3,320 | $2.35M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4,343 | 2,131 | $2.06M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 15,467 | 8,852 | $1.87M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 28,526 | 25,447 | $1.82M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,184 | 982 | $1.80M |
| 96375 | Therapeutic injection; each additional sequential IV push | 27,864 | 18,951 | $1.51M |
| 70450 | Computed tomography, head or brain; without contrast material | 7,451 | 6,183 | $1.40M |
| 80053 | Comprehensive metabolic panel | 144,228 | 95,177 | $1.31M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 4,138 | 3,310 | $1.21M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 5,040 | 4,241 | $1.18M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 38,322 | 27,817 | $1.10M |
| 93017 | 4,105 | 3,732 | $1.04M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18,706 | 11,863 | $963K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 36,803 | 21,754 | $919K |
| 95886 | 3,052 | 2,672 | $885K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3,364 | 2,962 | $856K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 7,881 | 7,441 | $780K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3,581 | 3,200 | $757K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8,904 | 8,669 | $718K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,825 | 5,980 | $706K |
| 36415 | Collection of venous blood by venipuncture | 147,778 | 85,897 | $697K |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,945 | 5,908 | $683K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 10,040 | 8,089 | $678K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 97,458 | 78,056 | $675K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,426 | 2,253 | $659K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 19,746 | 8,678 | $657K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,410 | 2,252 | $656K |
| 80050 | General health panel | 17,262 | 16,156 | $634K |
| 84443 | Thyroid stimulating hormone (TSH) | 42,156 | 39,052 | $624K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,749 | 2,361 | $598K |
| 59025 | Fetal non-stress test | 6,471 | 4,490 | $581K |
| 71045 | Radiologic examination, chest; single view | 20,748 | 16,917 | $573K |
| 96376 | 8,985 | 5,018 | $553K | |
| 74178 | 742 | 636 | $544K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 22,474 | 20,860 | $534K |
| 71250 | 3,572 | 3,119 | $531K | |
| 80061 | Lipid panel | 43,765 | 38,505 | $528K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11,470 | 4,234 | $482K |
| 76819 | Fetal biophysical profile; without non-stress testing | 5,783 | 4,099 | $474K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6,455 | 5,488 | $466K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,722 | 4,417 | $438K |
| C1769 | Guide wire | 3,365 | 2,874 | $432K |
| 96367 | 3,947 | 2,041 | $416K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,342 | 1,245 | $416K |
| 83880 | 12,728 | 11,028 | $400K | |
| 76642 | 4,332 | 4,065 | $395K | |
| 97597 | 3,667 | 810 | $395K | |
| 72141 | 1,471 | 1,308 | $390K | |
| 93971 | 2,170 | 1,952 | $373K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 929 | 663 | $364K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10,325 | 9,338 | $354K |
| 71046 | Radiologic examination, chest; 2 views | 11,871 | 10,312 | $346K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 801 | 553 | $337K |
| 96415 | 1,703 | 1,244 | $336K | |
| 77066 | Tomosynthesis, mammo | 4,150 | 3,529 | $331K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,538 | 4,126 | $323K |
| 80081 | 4,480 | 4,065 | $313K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 697 | 371 | $295K |
| 95910 | 860 | 797 | $289K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,102 | 5,332 | $284K |
| J2785 | Injection, regadenoson, 0.1 mg | 1,728 | 1,583 | $278K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 25,482 | 19,812 | $273K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10,017 | 9,289 | $271K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,337 | 1,174 | $266K |
| 73560 | 3,414 | 2,932 | $266K | |
| 72100 | 3,454 | 3,042 | $258K | |
| 77300 | 427 | 168 | $254K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 5,474 | 5,082 | $254K |
| 83036 | Hemoglobin; glycosylated (A1C) | 31,982 | 29,685 | $253K |
| 73221 | 874 | 796 | $245K | |
| 73630 | 2,783 | 2,500 | $239K | |
| 82607 | 17,911 | 16,610 | $237K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,664 | 2,365 | $235K |
| 84484 | 24,465 | 15,713 | $230K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,713 | 1,611 | $229K |
| 73030 | 2,999 | 2,512 | $228K | |
| 85027 | 35,661 | 30,959 | $222K | |
| 76775 | 1,266 | 1,201 | $221K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8,863 | 3,595 | $220K |
| 58571 | 161 | 107 | $214K | |
| 86803 | 16,723 | 15,551 | $207K | |
| 76536 | 2,134 | 2,038 | $206K | |
| 77336 | 1,864 | 519 | $205K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 26,640 | 23,771 | $203K |
| 72040 | 2,296 | 1,932 | $202K | |
| 70496 | 914 | 751 | $199K | |
| C1776 | Joint device (implantable) | 46 | 43 | $196K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 3,363 | 3,090 | $189K |
| 73610 | 2,297 | 2,002 | $183K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 3,612 | 2,957 | $180K |
| 80048 | Basic metabolic panel (calcium, ionized) | 21,909 | 15,330 | $179K |
| 74018 | 2,737 | 2,449 | $176K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,855 | 1,362 | $175K |
| 77065 | Tomosynthesis, mammo | 2,444 | 2,043 | $173K |
| 73130 | 1,848 | 1,672 | $173K | |
| 76830 | Ultrasound, transvaginal | 2,001 | 1,863 | $170K |
| 84439 | 19,907 | 18,108 | $166K | |
| 93325 | 1,853 | 1,693 | $166K | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,630 | 1,487 | $162K |
| 70498 | 793 | 686 | $159K | |
| 84702 | 11,484 | 8,849 | $158K | |
| 97161 | 5,198 | 3,608 | $155K | |
| 72110 | 997 | 887 | $152K | |
| 72131 | 694 | 604 | $152K | |
| 83690 | 26,478 | 23,320 | $151K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 16,339 | 12,089 | $150K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,875 | 1,633 | $144K |
| 80074 | 3,610 | 3,255 | $143K | |
| 93880 | 1,033 | 905 | $142K | |
| 74240 | 665 | 602 | $142K | |
| 76820 | 3,280 | 1,797 | $141K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,736 | 1,571 | $137K |
| 80306 | 9,384 | 8,315 | $136K | |
| 87507 | 480 | 448 | $134K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,768 | 5,291 | $128K |
| 88307 | 2,154 | 1,429 | $125K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,604 | 1,226 | $125K |
| J3490 | Unclassified drugs | 1,280 | 1,066 | $124K |
| 93970 | 536 | 471 | $120K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8,806 | 6,625 | $118K |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 7,704 | 6,765 | $117K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 401 | 370 | $114K |
| C1889 | Implantable/insertable device, not otherwise classified | 875 | 513 | $107K |
| 73502 | 1,828 | 1,574 | $107K | |
| 73110 | 1,160 | 1,028 | $105K | |
| 81001 | 32,723 | 28,164 | $103K | |
| 93976 | 822 | 758 | $101K | |
| 82728 | 8,197 | 7,395 | $101K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,203 | 3,540 | $100K |
| 75574 | 305 | 265 | $100K | |
| 81025 | 18,175 | 15,803 | $97K | |
| 82746 | 7,685 | 7,180 | $95K | |
| 84466 | 8,273 | 7,740 | $91K | |
| 87522 | Neg quan hep c or qual rna | 2,385 | 2,157 | $90K |
| 83605 | 10,381 | 8,012 | $89K | |
| 82962 | 17,338 | 7,524 | $87K | |
| 78431 | 522 | 192 | $87K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 919 | 862 | $86K |
| 84112 | 980 | 870 | $84K | |
| 96417 | 665 | 390 | $84K | |
| 95806 | 565 | 517 | $84K | |
| 77290 | 340 | 127 | $82K | |
| 83735 | 14,027 | 10,651 | $81K | |
| 84403 | 3,551 | 3,277 | $77K | |
| 84145 | 3,869 | 3,269 | $77K | |
| 78264 | 214 | 154 | $77K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 804 | 696 | $76K |
| 86850 | 9,426 | 8,333 | $76K | |
| 71271 | 1,188 | 1,102 | $72K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 14,775 | 9,251 | $69K |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 767 | 637 | $69K |
| 72156 | 181 | 160 | $69K | |
| 76825 | 794 | 702 | $68K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 10,346 | 9,323 | $66K |
| 70486 | 300 | 281 | $63K | |
| 77280 | 303 | 91 | $62K | |
| 83540 | 10,787 | 9,986 | $62K | |
| 87186 | 7,916 | 6,930 | $60K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,131 | 1,980 | $59K |
| 82670 | 2,352 | 2,141 | $59K | |
| 87040 | 7,318 | 3,464 | $59K | |
| 0100U | 292 | 211 | $58K | |
| 97162 | 2,187 | 1,276 | $57K | |
| 86480 | 1,068 | 1,000 | $56K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,614 | 1,351 | $55K |
| 87070 | 6,999 | 5,415 | $55K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 555 | 478 | $54K |
| 83001 | 3,259 | 3,028 | $53K | |
| 86235 | 635 | 574 | $51K | |
| 72072 | 550 | 475 | $51K | |
| 83013 | 827 | 788 | $51K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 4,376 | 3,081 | $50K |
| 82948 | 6,620 | 2,681 | $50K | |
| 87081 | 7,439 | 6,978 | $49K | |
| 84144 | 2,699 | 2,361 | $48K | |
| C1760 | Closure device, vascular (implantable/insertable) | 172 | 126 | $48K |
| C1874 | Stent, coated/covered, with delivery system | 34 | 29 | $47K |
| 19083 | 43 | 39 | $47K | |
| 72158 | 123 | 114 | $47K | |
| 86140 | 10,699 | 9,122 | $47K | |
| 85610 | 12,109 | 8,835 | $46K | |
| 77080 | 930 | 804 | $45K | |
| 74241 | 230 | 216 | $45K | |
| 86038 | 4,201 | 3,854 | $45K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 72 | 62 | $45K |
| 84402 | 2,110 | 1,949 | $45K | |
| 88342 | 1,438 | 1,058 | $44K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 892 | 626 | $44K |
| 82805 | 891 | 704 | $44K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 10,994 | 7,242 | $44K |
| 82784 | 3,008 | 2,725 | $43K | |
| 87340 | 4,928 | 4,580 | $43K | |
| 81003 | 17,838 | 16,026 | $43K | |
| 95911 | 120 | 111 | $42K | |
| 78227 | 111 | 87 | $42K | |
| 85379 | 4,797 | 4,409 | $41K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,942 | 1,821 | $41K |
| 87077 | 5,215 | 4,469 | $41K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,452 | 1,998 | $40K |
| J2704 | Injection, propofol, 10 mg | 11,267 | 8,010 | $38K |
| 84146 | 2,296 | 2,133 | $38K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,971 | 2,782 | $38K |
| A4648 | Tissue marker, implantable, any type, each | 322 | 280 | $37K |
| 99152 | 932 | 733 | $37K | |
| 93613 | 15 | 12 | $36K | |
| 82077 | 2,928 | 2,446 | $35K | |
| 88304 | 1,452 | 1,293 | $35K | |
| 70491 | 152 | 136 | $34K | |
| 83002 | 2,132 | 1,998 | $34K | |
| 93246 | 976 | 923 | $34K | |
| 0042T | 110 | 101 | $33K | |
| 87529 | 899 | 823 | $32K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,216 | 518 | $32K |
| 97165 | 1,191 | 962 | $31K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,723 | 4,364 | $31K |
| 84481 | 1,902 | 1,790 | $31K | |
| 73562 | 321 | 296 | $31K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,189 | 692 | $30K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 40 | 25 | $30K |
| 82043 | 5,636 | 5,058 | $28K | |
| 83516 | 1,630 | 962 | $28K | |
| 82247 | 4,745 | 3,431 | $28K | |
| 0002A | 1,018 | 994 | $27K | |
| 83615 | 4,650 | 3,665 | $27K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,353 | 1,395 | $26K |
| 76801 | 314 | 286 | $26K | |
| 86901 | 8,039 | 7,051 | $26K | |
| 76885 | 243 | 233 | $26K | |
| 87147 | 3,483 | 2,487 | $25K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 3,705 | 1,476 | $25K |
| 86900 | 8,156 | 7,064 | $25K | |
| 0001A | 1,117 | 1,065 | $25K | |
| 84550 | 6,145 | 5,087 | $24K | |
| 85730 | 3,911 | 3,391 | $24K | |
| 76870 | 288 | 270 | $23K | |
| 82570 | 5,177 | 4,868 | $23K | |
| 82550 | 3,751 | 3,081 | $23K | |
| 87205 | 6,057 | 5,427 | $23K | |
| 94010 | 394 | 341 | $23K | |
| 47562 | 12 | 12 | $22K | |
| 86592 | 5,322 | 4,946 | $22K | |
| 95816 | 79 | 76 | $22K | |
| 83970 | 625 | 569 | $22K | |
| 85652 | 9,029 | 7,862 | $22K | |
| 86696 | 1,240 | 949 | $21K | |
| 94729 | 634 | 602 | $21K | |
| 86376 | 1,660 | 1,562 | $21K | |
| 78492 | 62 | 49 | $21K | |
| 86780 | 1,951 | 1,833 | $21K | |
| 86706 | 2,172 | 1,999 | $20K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,036 | 2,112 | $20K |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 165 | 153 | $20K |
| 84132 | 4,383 | 3,577 | $20K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,237 | 774 | $19K |
| 82950 | 5,790 | 5,384 | $19K | |
| 36591 | 1,074 | 401 | $19K | |
| 86762 | 1,561 | 1,473 | $19K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 5,591 | 4,943 | $19K |
| 82565 | 3,569 | 2,622 | $18K | |
| C1732 | Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping | 16 | 12 | $18K |
| 94664 | 715 | 330 | $18K | |
| 77412 | 108 | 12 | $18K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 25,976 | 19,516 | $18K |
| 97116 | 1,565 | 829 | $17K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,440 | 4,318 | $17K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,086 | 468 | $17K |
| 87493 | 592 | 542 | $17K | |
| 82627 | 813 | 749 | $17K | |
| 74455 | 76 | 71 | $17K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,798 | 2,279 | $17K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 13,462 | 9,507 | $16K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13,754 | 11,448 | $16K |
| 86704 | 1,500 | 1,344 | $16K | |
| 84450 | 3,503 | 2,728 | $16K | |
| 84460 | 3,528 | 2,762 | $16K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,026 | 1,604 | $15K |
| J1644 | Injection, heparin sodium, per 1000 units | 7,320 | 3,591 | $15K |
| 86695 | 1,176 | 948 | $15K | |
| 86431 | 2,747 | 2,531 | $15K | |
| 84075 | 3,114 | 2,398 | $15K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 571 | 474 | $15K |
| 80047 | 1,643 | 1,183 | $15K | |
| 99153 | Mod sedat endo service >5yrs | 169 | 144 | $14K |
| 80143 | 891 | 804 | $14K | |
| 73590 | 187 | 169 | $14K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 976 | 486 | $14K |
| 84165 | 835 | 766 | $13K | |
| 86003 | 151 | 135 | $13K | |
| 82533 | 929 | 751 | $13K | |
| 86364 | 1,000 | 964 | $13K | |
| 86800 | 948 | 895 | $13K | |
| 88341 | 180 | 139 | $13K | |
| 84100 | 2,793 | 1,929 | $12K | |
| 94727 | 345 | 326 | $12K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 65 | 51 | $12K |
| 80179 | 836 | 764 | $11K | |
| 87902 | 53 | 50 | $11K | |
| 87641 | 404 | 367 | $11K | |
| 87088 | 1,572 | 1,493 | $11K | |
| C1730 | Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) | 33 | 26 | $11K |
| 36416 | 4,486 | 1,963 | $11K | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 2,242 | 1,055 | $11K |
| 74183 | 34 | 29 | $11K | |
| 72132 | 48 | 36 | $11K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 721 | 612 | $11K |
| 77334 | 16 | 12 | $11K | |
| 94726 | 220 | 208 | $10K | |
| 82947 | 3,021 | 2,547 | $10K | |
| J3411 | Injection, thiamine hcl, 100 mg | 1,671 | 869 | $10K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 59 | 56 | $10K |
| 76813 | 131 | 122 | $10K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 14 | 12 | $10K |
| 94060 | 96 | 85 | $10K | |
| 92523 | 162 | 143 | $10K | |
| 93623 | 17 | 13 | $10K | |
| 82150 | 1,517 | 1,392 | $10K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 469 | 212 | $9K |
| 77049 | 29 | 26 | $9K | |
| 86258 | 544 | 521 | $9K | |
| 72120 | 114 | 98 | $9K | |
| 83921 | 520 | 479 | $9K | |
| 87481 | 271 | 144 | $9K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 122 | 109 | $8K |
| 86147 | 178 | 160 | $8K | |
| 86231 | 859 | 828 | $8K | |
| 86787 | 750 | 707 | $8K | |
| 85014 | 3,933 | 3,114 | $8K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,065 | 5,114 | $8K |
| 82248 | 1,792 | 1,243 | $8K | |
| 82330 | 773 | 583 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,906 | 2,861 | $8K |
| 80076 | 996 | 805 | $8K | |
| 96368 | 100 | 66 | $8K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,694 | 4,551 | $7K |
| 36430 | 21 | 13 | $7K | |
| 88302 | 319 | 271 | $7K | |
| 0097U | 50 | 26 | $7K | |
| 86708 | 704 | 644 | $7K | |
| 51600 | 76 | 71 | $7K | |
| 83655 | 603 | 588 | $7K | |
| 86334 | 259 | 234 | $7K | |
| 85347 | 296 | 137 | $7K | |
| 83520 | 420 | 273 | $7K | |
| 84480 | 529 | 501 | $7K | |
| 86255 | 504 | 431 | $7K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,554 | 1,055 | $7K |
| 86225 | 552 | 495 | $6K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 99 | 91 | $6K |
| J1790 | Injection, droperidol, up to 5 mg | 1,250 | 1,115 | $6K |
| 83550 | 694 | 630 | $6K | |
| 86665 | 173 | 158 | $6K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,137 | 1,557 | $6K |
| 81374 | 98 | 96 | $6K | |
| 73070 | 91 | 69 | $6K | |
| 78226 | 20 | 13 | $6K | |
| 83498 | 247 | 221 | $6K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 21 | 13 | $6K |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 3,264 | 3,040 | $5K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,308 | 1,013 | $5K |
| 84445 | 122 | 119 | $5K | |
| 82951 | 511 | 474 | $5K | |
| J2805 | Injection, sincalide, 5 micrograms | 57 | 52 | $5K |
| 0296T | 142 | 122 | $5K | |
| 84153 | 300 | 272 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,088 | 2,330 | $5K |
| 90715 | 166 | 153 | $5K | |
| 84156 | 1,423 | 1,258 | $5K | |
| 83525 | 456 | 437 | $4K | |
| 85018 | 2,315 | 1,679 | $4K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 1,650 | 1,238 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,498 | 992 | $4K |
| 86200 | 358 | 348 | $4K | |
| 71101 | 38 | 37 | $4K | |
| 84436 | 721 | 629 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 61 | 24 | $4K |
| 87046 | 310 | 178 | $4K | |
| J3360 | Injection, diazepam, up to 5 mg | 220 | 163 | $4K |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 780 | 582 | $4K |
| 70544 | 14 | 13 | $4K | |
| 95909 | 15 | 14 | $4K | |
| 93975 | 12 | 12 | $4K | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 1,058 | 669 | $4K |
| 29581 | 144 | 24 | $4K | |
| 82140 | 307 | 267 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 2,528 | 1,923 | $3K |
| 80069 | 547 | 383 | $3K | |
| 82652 | 126 | 114 | $3K | |
| C1819 | Surgical tissue localization and excision device (implantable) | 14 | 13 | $3K |
| 36600 | 190 | 155 | $3K | |
| 72146 | 14 | 13 | $3K | |
| G0379 | Direct admission of patient for hospital observation care | 14 | 12 | $3K |
| 82803 | 161 | 132 | $3K | |
| 97166 | 192 | 117 | $3K | |
| 87807 | 218 | 214 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 275 | 249 | $3K |
| 72050 | 28 | 24 | $3K | |
| 76942 | 71 | 53 | $3K | |
| 86304 | 77 | 64 | $3K | |
| 95819 | 15 | 15 | $3K | |
| 82977 | 451 | 429 | $3K | |
| 94761 | 374 | 176 | $3K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 262 | 206 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 37 | 36 | $3K |
| 82785 | 170 | 127 | $3K | |
| J1453 | Injection, fosaprepitant, 1 mg | 64 | 38 | $3K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 536 | 454 | $3K |
| 82172 | 167 | 122 | $3K | |
| 84425 | 144 | 139 | $3K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 698 | 497 | $2K |
| 86308 | 542 | 511 | $2K | |
| 82105 | 143 | 135 | $2K | |
| 87109 | 101 | 86 | $2K | |
| 87210 | 497 | 477 | $2K | |
| 73140 | 38 | 37 | $2K | |
| 92610 | 53 | 41 | $2K | |
| 82375 | 242 | 173 | $2K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 49 | 48 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 31 | 28 | $2K |
| 97010 | 247 | 141 | $2K | |
| 87045 | 288 | 210 | $2K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 783 | 627 | $2K |
| 86481 | 24 | 22 | $2K | |
| 72114 | 13 | 13 | $2K | |
| 93242 | 57 | 56 | $2K | |
| 87220 | 455 | 434 | $2K | |
| 86146 | 34 | 31 | $2K | |
| 10060 | 15 | 13 | $2K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 84 | 46 | $2K |
| 86160 | 95 | 91 | $2K | |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 189 | 143 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 3,640 | 1,745 | $2K |
| 86664 | 116 | 106 | $2K | |
| 96040 | 63 | 63 | $2K | |
| 82024 | 37 | 34 | $2K | |
| 81002 | 454 | 361 | $2K | |
| 81596 | 28 | 27 | $2K | |
| J3480 | Injection, potassium chloride, per 2 meq | 311 | 185 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 53 | 53 | $2K |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 78 | 70 | $2K |
| 86769 | 48 | 39 | $2K | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 294 | 69 | $2K |
| 85045 | 479 | 432 | $2K | |
| 76882 | 12 | 12 | $2K | |
| 82952 | 462 | 438 | $1K | |
| 83010 | 136 | 134 | $1K | |
| 86037 | 50 | 47 | $1K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 77 | 72 | $1K |
| 86381 | 65 | 61 | $1K | |
| 0012A | 63 | 59 | $1K | |
| 83050 | 223 | 169 | $1K | |
| 86677 | 27 | 26 | $1K | |
| 86430 | 210 | 184 | $1K | |
| 87209 | 64 | 60 | $1K | |
| 86870 | 55 | 50 | $1K | |
| 86663 | 87 | 80 | $1K | |
| 84134 | 99 | 91 | $1K | |
| 73090 | 17 | 14 | $1K | |
| 82103 | 73 | 65 | $1K | |
| 82010 | 166 | 137 | $1K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 116 | 94 | $981.39 |
| J9045 | Injection, carboplatin, 50 mg | 32 | 13 | $965.78 |
| 84703 | 128 | 125 | $941.33 | |
| 83721 | 109 | 103 | $919.09 | |
| 86015 | 78 | 74 | $825.54 | |
| 84295 | 200 | 169 | $793.66 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 43 | 40 | $790.92 |
| 86618 | 29 | 28 | $741.59 | |
| 86923 | 24 | 17 | $721.84 | |
| J2404 | Injection, nicardipine, 0.1 mg | 239 | 202 | $696.43 |
| 84207 | 29 | 26 | $680.98 | |
| 81050 | 162 | 135 | $594.39 | |
| 83883 | 39 | 39 | $578.20 | |
| 85613 | 49 | 45 | $577.69 | |
| 0011A | 69 | 61 | $557.46 | |
| 88312 | 21 | 16 | $548.61 | |
| 87177 | 58 | 50 | $524.30 | |
| 97802 | 65 | 62 | $522.17 | |
| 93270 | 12 | 12 | $504.90 | |
| 82164 | 34 | 26 | $475.52 | |
| 97803 | 43 | 40 | $469.46 | |
| 86707 | 44 | 40 | $451.23 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 108 | 93 | $449.42 |
| 87350 | 43 | 39 | $438.14 | |
| J1940 | Injection, furosemide, up to 20 mg | 161 | 106 | $413.03 |
| 83993 | 17 | 17 | $412.31 | |
| 82270 | 117 | 104 | $388.16 | |
| 82378 | 29 | 25 | $382.37 | |
| 90686 | 12 | 12 | $382.01 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 123 | 97 | $380.36 |
| 87102 | 59 | 51 | $355.71 | |
| 82465 | 96 | 92 | $353.65 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 229 | 162 | $334.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 36 | 26 | $333.21 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 68 | 54 | $321.75 |
| G0008 | Administration of influenza virus vaccine | 27 | 25 | $315.72 |
| 86705 | 31 | 28 | $306.02 | |
| 84155 | 129 | 113 | $298.44 | |
| 0004A | 15 | 13 | $284.00 | |
| 84681 | 12 | 12 | $249.72 | |
| 81015 | 66 | 66 | $248.79 | |
| 85598 | 16 | 15 | $220.34 | |
| 87116 | 33 | 27 | $216.00 | |
| 87206 | 70 | 39 | $211.20 | |
| 84478 | 35 | 26 | $188.07 | |
| 82085 | 26 | 25 | $186.14 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 361 | 261 | $175.16 |
| 80164 | 13 | 12 | $167.20 | |
| 87449 | 15 | 14 | $157.80 | |
| 85670 | 32 | 28 | $156.71 | |
| C1755 | Catheter, intraspinal | 12 | 12 | $134.37 |
| 86362 | 13 | 13 | $132.55 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 491 | 440 | $132.36 |
| 85007 | 40 | 39 | $119.82 | |
| 86141 | 13 | 13 | $116.55 | |
| 94760 | 18 | 14 | $114.72 | |
| J2720 | Injection, protamine sulfate, per 10 mg | 19 | 13 | $112.90 |
| 87075 | 15 | 13 | $101.44 | |
| 99499 | 155 | 136 | $97.89 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 15 | 12 | $89.59 |
| 80178 | 12 | 12 | $83.25 | |
| J2305 | Injection, nitroglycerin, 5 mg | 17 | 16 | $74.64 |
| 87185 | 14 | 12 | $70.32 | |
| 82310 | 21 | 13 | $67.08 | |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 34 | 29 | $58.60 |
| J1953 | Injection, levetiracetam, 10 mg | 17 | 12 | $55.70 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 41 | 41 | $53.46 |
| 85732 | 12 | 12 | $37.21 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 28 | 26 | $0.00 |